Global Cancer Gene Therapy Market Size Study, By End-User (Diagnostics Centers, Hospitals, Research Institutes), By Therapy (Oncolytic Virotherapy, Gene induced immunotherapy, Gene transfer and others), and Regional Forecasts, 2017-2025 (USD Billion/Million)

Global Cancer Gene Therapy Market industry valued approximately USD 0.2 billion in 2016 is anticipated to grow with a healthy growth rate of more than 35.1% over the forecast period 2017-2025. The major factors driving the growth are rising need for Cancer Gene Therapy worldwide, increase in prevalence of cancer, increase in geriatric population, increase in funding for R&D activities of cancer gene therapy and favorable government regulations.

The objective of the study is to define market sizes of different segments & countries in previous years and to forecast the values to the next eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry with respect to each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as drivers & restraining factors which will define the future growth of the market. Additionally, it will also incorporate the opportunities available in micro markets for stakeholders to invest, detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

End-User:
 Diagnostics Centers
 Hospitals
 Research Institutes

Therapy:
 Oncolytic Virotherapy
 Gene Induced Immunotherapy
 Gene transfer
 Others

Regions:
 North America
o U.S.
o Canada
 Europe
o UK
o Germany
 Asia Pacific
o China
o India
o Japan
 Latin America
o Brazil
o Mexico
 Rest of the World

Furthermore, the years considered for the study are as follows:

Historical year - 2015
Base year - 2016
Forecast period - 2017 to 2025

Some of the key manufacturers involved in the market are OncoGenex Pharmaceuticals, Adaptimmune,
Merck, Bluebird bio, Inc,GlaxoSmithKline, Shanghai Sunway Biotech, BioCancell, Celgene, Shenzhen SiBiono GeneTech and SynerGene Therapeutics.Acquisitions and effective mergers are some of the strategies adopted by the key manufacturers. New product launches and focuses on continuous technology innovations are also strategies adopted by the major players. The companies are also trying to dominate the market by investing in research and development.

Target Audience of the Cancer Gene Therapy Market Study

 Key Consulting Companies & Advisors
 Large, medium-sized, and small enterprises
 Venture capitalists
 Value-Added Resellers (VARs)
 Third-party knowledge providers
 Investment bankers
 Investors

Geography Analysis:

The report further discusses the market opportunity, compound annual growth rate (CAGR) growth rate, competition, new technology innovations, market players analysis, government guidelines, export and import (EXIM) analysis, historical revenues, future forecasts etc. in the following regions and/or countries:

• North America (U.S. & Canada) Market Size, Y-O-Y Growth, Market Players Analysis & Opportunity Outlook
• Latin America (Brazil, Mexico, Argentina, Rest of Latin America) Market Size, Y-O-Y Growth & Market Players Analysis & Opportunity Outlook
• Europe (U.K., Germany, France, Italy, Spain, Hungary, Belgium, Netherlands & Luxembourg, NORDIC(Finland, Sweden, Norway, Denmark), Ireland, Switzerland, Austria, Poland, Turkey, Russia, Rest of Europe), Poland, Turkey, Russia, Rest of Europe) Market Size, Y-O-Y Growth Market Players Analys  & Opportunity Outlook
• Asia-Pacific (China, India, Japan, South Korea, Singapore, Indonesia, Malaysia, Australia, New Zealand, Rest of Asia-Pacific) Market Size, Y-O-Y Growth & Market Players Analysis & Opportunity Outlook
• Middle East and Africa  (Israel, GCC (Saudi Arabia, UAE, Bahrain, Kuwait, Qatar, Oman), North Africa, South Africa, Rest of Middle East and Africa) Market Size, Y-O-Y Growth Market Players Analysis & Opportunity Outlook

.